Type Here to Get Search Results !

Ozempic maker Novo Nordisk lowers growth outlook for its weight loss drugs as pricing pressures mount

Novo Nordisk is currently locked in a bidding war with Pfizer for U.S. biotech firm Metsera.

from US Top News and Analysis https://ift.tt/cLe8r7q
Tags

Post a Comment

0 Comments
* Please Don't Spam Here. All the Comments are Reviewed by Admin.

Top Post Ad

Below Post Ad